Sevion is a biopharmaceutical company which discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The Company is advancing a pipeline of proprietary and partnered product candidates that leverages its unique antibody technology platforms.

from http://www.seviontherapeutics.com/about/

Publications show all

Sevion Therapeutics has published 3 articles.

SEC Filings show all

8-K21010-Q3610-K11D3S-11